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Abstract-Development of a nonimmunologically induced experimental asthma model using compound 48/80 was attempted.
Male mongrel dogs anesthetized with pentobarbital-Na were immobilized with decamethonium bromide under artificial respiration.
Airway resistance was measured with a modified Konzett Rbssler method and expressed as a change in ventilation overflow (VO). Inhalation of compound 48/80 caused no change in VO even in high concentrations up to a 1 % solution.
Infusion of compound 48/80 into the bronchial artery at a dose of 0.2 mg/min for 10 min by using the right bronchial perfusion method caused a marked increase in VO accompanied by decreases in perfusion pressure and systemic blood pressure.
The compound 48/80-induced bronchoconstriction was inhibited 58% by surgical vagotomy and was almost abolished by chlorpheniramine (10 mg/kg, intraduodenally (i.d.)). Disodium cromoglycate (inhalation of 1% solution along with 5 mg/kg, i.v.), tranilast (300 mg/kg, i.d.) and NCO-650, a new antiallergic drug (100 mg/kg, i.d.) significantly inhibited the compound 48/80 induced bronchoconstriction.
These results indicate that 1) compound 48/80 infusion into the bronchial artery produces an asthma-like bronchoconstriction, 2) the main chemical mediator involved in this response would be histamine acting through H1-receptors, and 3) effects of mast cell stabilizers can be evaluated with this model. Bronchial asthma attack is known to be initiated not only by inhalation of some specific allergens but also by nonimmuno logical stimuli such as cold air, exercise, mental stress and infection. In vivo nonim munological asthma models have not been, however, so much available as compared with allergic asthma models.
Compound 48/80 has been widely used to release chemical mediators such as histamine and leukotrienes from mast cells in in vitro experiments (1) . However, the in vivo effect of compound 48/80 on the respiratory tract has been poorly documented.
Leff et al. (2) reported that administration of compound 48/80 into the cranial thyroid arteries caused an increase in tracheal tension and a re lease of histamine. This is the only report in which reactivity of the upper trachea to this agent was investigated. On the other hand, reactivities of bronchi and bronchioles are much more significant in bronchial asthma.
and ventilated artificially with a respirator (Natsume, KN-50) at a frequency of 30 breaths/min. Respiratory volume was adjusted at the beginning of the experiment for venti lation overflow to be 2.5 ml/kg in each dog.
Two types of experiments were done: one was inhalation of compound 48/80, and the other was infusion of the agent into the bronchial artery.
The bronchial artery perfusion (BAP) method (3) was used to infuse compound 48/80 into the bronchial artery. The chest was opened at the right fourth intercostal space. After heparinization (initial dose of 1000 units/kg, i.v., and supplemental doses of 500 units/kg, i.v., every hour), the right bronchial artery originating from one of the right inter costal arteries was cannulated and perfused with the dog's own blood delivered from the right femoral artery, using a constant flow pump (Tokyo Rika Kikai, MP-201). The flow was adjusted at the beginning of each exper iment so that the perfusion pressure was approximately equal to the systemic arterial blood pressure, and it was kept constant throughout the experiment. The perfusion pressure was measured between the pump and the perfused artery via a pressure trans ducer (Nihon Kohden, MPU-0.5), and it was used as an index of the change in bronchial arterial resistance. The systemic arterial blood pressure and heart rate were moni tored from the cannulated left femoral artery via a pressure transducer and tachometer (Nihon Kohden RT-5), respectively. These recordings were made on a polygraph (Nihon Kohden, RM-85). The perfused area in the lungs of the cannulated right bronchial artery was confirmed at the end of each experiment by injecting 1 % Evans blue solution at a volume of 5 ml into the artery. It was found that almost all of the bronchioles in the right lung and the right main bronchus were stained by the dye in most cases, while the left lung and alveoli in either lung were not substan tially stained.
Acute surgical vagotomy was performed by sectioning the bilateral cervical vagi and superior laryngeal nerves.
Application of compound 48/80: Inha lations of compound 48/80 and histamine were made for 10 min at a volume of about 3 ml with the use of an ultrasonic nebulizer (Nihon Kohden, TUR-3000) introduced into the respiratory circuit.
Close intraarterial infusion of compound 48/80 was made into the perfused bronchial artery through the rubber tubing at a rate of 0.08 ml/min using an infusion pump (Natsu me, . Before the infusion of com pound 48/80, histamine (1, 3 and 10 jig/ body) was injected closely into the perfused bronchial artery at a volume of 0.1 ml in 5 sec to examine the reactivity to histamine. The animals that did not respond to histamine even at a dose of 10,ug were not used in the experiment.
Determination of airway constriction: In anesthetized and immobilized dogs, the bronchomotor tone was measured by a mod ification of the Konzett-Rossler method (4). The lung was inflated at a fixed volume of air under a constant pressure (10 cmH2O , and chlor pheniramine maleate (Tokyo Kasei). All these drugs were dissolved in saline when used for intraarterial administration, and they were suspended in 5% arabic gum solution when used for intraduodenal (i.d.) administration, at the time of usage. The doses of NCO-650 and disodium cromoglycate were expressed as their respective salts. The doses of the other drugs were expressed as the respective bases. In the experiments for i.d. administra tion, the animals were fasted overnight before use and drugs were administered through a tube intubated from the stomach wall.
Statistical analysis: All values were ex pressed as the mean with S.E. Statistical significance of difference was detemined by Student's t-test. Perfusion pressure began to decrease immediately after the start of infusion of compound 48/80. A slight to moderate decrease in systemic blood pressure and a slight decrease in heart rate were also observed.
Time course of the change in ventilation overflow induced by close intraarterial in fusion of compound 48/80 is shown in Fig.  2 . The maximal changes in ventilation over flow at doses of 0.1 and 0.2 mg/min were 7.7±4.6 ml (N=7) and 17.7±1.2 ml (N=9), respectively.
Changes in perfusion pressure and sys temic blood pressure are shown in Fig-3 . The mean basal blood flow of the perfused artery was 2.2±0.6 ml/min (N=13).
Decreases in perfusion pressure and systemic blood pres sure at 0.1 mg/min were 17.8±7.6 mmHg and 1 2.6±2.7 mmHg, respectively, and at 0.2 mg/ min, 29.5±4.9 mmHg and 36.9±7.9 mmHg, respectively. The dogs that did not respond to an intraarterial injection of even at a dose of 10 /og did not respond to compound 48/80.
Effect of vagotomy on the compound 48/ 80-induced bronchoconstriction:
The effect of vagotomy on the change in ventilation overflow induced by intraarterial infusion of compound 48/80 at a dose of 0.2 mg/min is shown in Fig. 4 . The maximal increase in ventilation overflow in the vagotomized group was 7.5±5.6 ml (N=8) as compared with the control value of 17.7±1.2 ml (N=9).
The inhibition ratio to the maximal increase was 58% and statistically significant. The decreases in perfusion pressure and systemic blood pressure caused by compound 48/80 were also inhibited (Fig. 5) . Surgical vagotomy by itself caused no change in ventilation over flow, perfusion pressure and systemic blood pressure.
Effect of chlorpheniramine on the com pound 48/80-induced bronchoconstriction: Effect of chlorpheniramine on the broncho constriction induced by intraarterial infusion of compound 48/80 at a dose of 0.2 mg/min is shown in Fig. 4 . Chlorpheniramine at a dose of 10 mg/kg, i.d., administered 60 min prior to the intraarterial infusion of compound 48/ 80 almost abolished the increase in venti lation overflow induced by compound 48/80. The inhibition ratio to the maximal increase in ventilation overflow was 88%. The decrease in perfusion pressure induced by compound 48/ 80 also almost disappeared, and decreases in systemic blood pressure and heart rate were moderately inhibited (Fig. 5) . Effects of mast cell stabilizers on the com pound 48/80-induced bronchoconstriction: Effects of disodium cromoglycate, tranilast and NCO-650, a new antiallergic drug, on the bronchoconstriction induced by intra arterial infusion of compound 48/80 at a dose of 0.2 mg/min are shown in Fig. 6 . Inhalation of 11% solution along with 5 mg/kg, i.v., of dis odium cromoglycate, and i.d. administrations of tranilast at a dose of 300 mg/kg and NCO 650 at a dose of 100 mg/kg, significantly inhibited the increase in ventilation overflow. The inhibition ratios to the maximal increase in ventilation overflow in the control group were 59, 42 and 64%, respectively. Effects of disodium cromoglycate, tranilast and NCO 650 on the decreases in perfusion pressure and systemic blood pressure induced by com pound 48/80 are shown in Fig. 7 . The de creases in perfusion pressure and systemic blood pressure were significantly inhibited by these drugs.
NCO-650 at a dose of 100 mg/kg, i.d., which significantly inhibited the compound 48/80-induced bronchoconstriction did not inhibit the increase in ventilation overflow induced by inhalation of histamine for 10 min in concentrations of 0.005-0.01%, the maxi mal increase in the histamine alone response was 15.0±4.5 ml, and that in the response after NCO-650 treatment was 14.3±2.7 ml (N =4). Inhaled agents have to pass many tissues to reach interstitial mast cells and to cause effects. Compound 48/80 is a synthetic poly amine produced by the condensation of N-methyl-p-methoxyphenethylamine and formaldehyde (11) . Since its mean molecular weight is about 1300, it may be too massive to penetrate into tissue layers, This could be a possible reason for the finding that no bron choconstriction occurred by inhalation of compound 48/80 in the present study.
In the second experiment, we infused compound 48/80 directly into the bronchial artery using the right bronchial artery per fusion (BAP) method. Compound 48/80 at a dose of 0.2 mg/min produced a remarkable asthma-like bronchoconstriction in all the animals tested.
The bronchoconstrictive response had a characteristic pattern that a 5-7 min delay time existed following the start of infusion until the bronchocons triction began to occur. Administrations of histamine, acetylcholine and Ascaris suum antigen into the bronchial artery provoke a rapid increase in ventilation overflow im mediately after administrations of these agents (3, 12) . In in vitro experiments using rat peritoneal mast cells, addition of com pound 48/80 results in an immediate release of histamine (13) (14) (15) It is reported that the vagal reflex is involved in the regulation of airway muscular tone through the sensory receptors such as irritant receptors, stretch receptors and C-fiber endings (20) (21) (22) . Allergic asthma in humans (23) and type I allergic asthma in dogs induced by Ascaris antigen (24) are partially inhibited by atropine. The compound 48/80 induced bronchoconstriction was inhibited 58% by surgical vagotomy in the present study. It is thus suggested that the vagal reflex is involved in the compound 48/80 induced bronchoconstriction, too, probably via histamine action. Decreases in perfusion pressure and systemic blood pressure were also inhibited by surgical vagotomy. The mechanism of the inhibitory effect is not clear. The vagal reflex may also be responsible for part of the vascular reactions.
The compound 48/80-induced broncho constriction was almost abolished by chlor pheniramine.
Histamine-induced broncho constriction in dogs is abolished or strongly inhibited by histamine Hi-receptor antago nists (25, 26) , whereas it is not effected by an H2-receptor antagonist, cimetidine (25) . That is, the histamine-induced broncho constriction in dogs is mainly through H1 receptors. Leff et al. (2) reported that adminis tration of compound 48/80 into the cranial thyroid arteries in dogs caused an increase in tracheal tension, a decrease in histamine content of the upper trachea and an increase in blood histamine concentration.
The dose of chlorpheniramine they used was 5 mg/kg, i.v. They confirmed that this dose caused a spe cific antagonism against histamine without influencing the response to acetylcholine. In our study, 10 mg/kg, i.d., of chlorphenir amine was used. Taking consideration of the difference of administration routes, the dose we used would also inhibit histamine spe cifically.
Compound 48/80 releases arachidonic acid as well as histamine from rat peritoneal mast cells in vitro (27). However, the chief mediator which was involved in the com pound 48/80-induced bronchoconstriction in the present study would be histamine, be cause 1) the response was almost abolished by chlorpheniramine, 2) the dogs that were poorly sensitive to a close intraarterial injec tion of histamine did not respond to compound 48/80 and 3) dogs are substantially insensi tive against leukotrienes (28).
Ascaris antigen-induced asthma in dogs is quite different from compund 48/80-induced asthma in which H1-receptor antagonists are only slightly effective (26) . In these two asthma models, mast cells are considered to be involved. So, different mediators are pro bably released from mast cells between the two responses. It is worthwhile to investigate the mechanisms by which different chemical mediators are released from mast cells of the airway tissues depending on the type of stimulus.
In the present study, disodium cromglycate, tranilast and NCO-650 significantly inhibited the compound 48/80-induced bronchocons triction at doses comparable with those which inhibit Ascaris antigen-induced asthma (29), indicating the effectiveness of mast cell stabilizers on the bronchial asthma model using compound 48/80 in dogs. Compound 48/80 is often used in vitro for screening antiasthma agents. However, mast cells used in such cases are usually from tissues other than the airway system. As mentioned above, mast cells from different tissues are hetero geneous. Additionally, complex participations of some nervous systems and hormones have to be taken into consideration in bronchial asthma.Therefore, the in vivo asthmatic model using compound 48/80 is considered to be quite useful as a screening model for anti allergic agents.
While the present model has varoius ad vantages, there would be a discrepancy in the chemical mediators involved in the responses between allergy-induced asthmas and com pound 48/80-induced bronchial asthma model will, nevertheless, contribute to the study on antiallergic drugs and airway mast cells.
